XBiotech (XBIT) Cash & Current Investments (2014 - 2026)
XBiotech's Cash & Current Investments came in at $109.53 million for Q2 2026, down 28.4% from $152.94 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Cash & Current Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, XBiotech's Cash & Current Investments was $125.55 million, down 27.3% from FY2024.
- Cash & Current Investments has declined in each of the last six years, with a five-year compound annual growth rate of -12.0% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $172.68 million in FY2024 (-13.7%), $200.02 million in FY2023 (-8.0%), $217.48 million in FY2022 (-8.2%) and $236.98 million in FY2021 (-0.2%).
- The Q2 2026 figure represents the lowest quarterly Cash & Current Investments since Q3 2019.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2021 (growth of 0.2%), and the weakest in Q2 2022 (a decline of 28.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.91 Bn | 1,109.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 634.46 Bn | 554.32 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 500.42 Bn | 473.54 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 355.19 Bn | 309.56 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 300.18 Bn | 264.17 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 263.17 Bn | 236.86 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.83 Bn | 193.23 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.81 Bn | 168.01 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 170.12 Bn | 116.76 Bn | 10.94 Bn | 11.70 Bn |
| 10 | XBiotech | 57.62 Mn | -477.80 Mn | - | 109.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 109.53 Mn |
| Dec 31, 2025 | 125.55 Mn |
| Sep 30, 2025 | 147.40 Mn |
| Jun 30, 2025 | 152.94 Mn |
| Mar 31, 2025 | 155.90 Mn |
| Dec 31, 2024 | 172.68 Mn |
| Sep 30, 2024 | 183.12 Mn |
| Jun 30, 2024 | 188.53 Mn |
| Mar 31, 2024 | 201.04 Mn |
| Dec 31, 2023 | 200.02 Mn |
| Sep 30, 2023 | 202.20 Mn |
| Jun 30, 2023 | 204.78 Mn |
| Mar 31, 2023 | 212.68 Mn |
| Dec 31, 2022 | 217.48 Mn |
| Sep 30, 2022 | 220.13 Mn |
| Jun 30, 2022 | 225.80 Mn |
| Mar 31, 2022 | 231.82 Mn |
| Dec 31, 2021 | 236.98 Mn |
| Sep 30, 2021 | 238.90 Mn |
| Jun 30, 2021 | 315.30 Mn |
API Access
XBiotech Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();